SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001628280-15-002164
Filing Date
2015-04-03
Accepted
2015-04-03 16:39:17
Documents
4
Effectiveness Date
2015-04-03

Document Format Files

Seq Description Document Type Size
1 S-8 rvncs-8.htm S-8 98453
2 EXHIBIT 5.1 rvncexhibit51.htm EX-5.1 9643
3 EXHIBIT 23.1 rvncexhibit231.htm EX-23.1 2443
4 GRAPHIC rvncgraphic1.jpg GRAPHIC 30400
  Complete submission text file 0001628280-15-002164.txt   153533
Mailing Address 7555 GATEWAY BLVD. NEWARK CA 94560
Business Address 7555 GATEWAY BLVD. NEWARK CA 94560 510-742-3400
Revance Therapeutics, Inc. (Filer) CIK: 0001479290 (see all company filings)

IRS No.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-203235 | Film No.: 15751659
SIC: 2834 Pharmaceutical Preparations